Physician profile
John Croker
NPI 1518927763
$1,229.58
in general payments reported to CMS, 2019-2025
21 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $269 · 2022: $224 · 2023: $191 · 2024: $370 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $249.43 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $149.76 | 2021-2024 | Rexulti |
| Lundbeck LLC | $138.54 | 2024-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $122.08 | 2021-2024 | |
| Reprise Biomedical, INC. | $97.87 | 2024 | Miro3d |
| Astellas Pharma US INC | $50.65 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $46.20 | 2024-2025 | Airsupra |
| Organogenesis INC. | $45.59 | 2021 | |
| Indivior INC. | $40.89 | 2023-2025 | Sublocade |
| Smith+Nephew, INC. | $37.89 | 2022-2023 | Pico, Renasys Go V2 Home |
| Exact Sciences Corporation | $35.68 | 2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $35.31 | 2021 | |
| Glaxosmithkline, LLC. | $29.36 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Alk-Abello, INC | $28.78 | 2024 | Ragwitek, Odactra, Grastek |
| Tactile Systems Technology INC | $20.52 | 2025 | Flexitouch Plus, Nimbl |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $19.75 | 2021 | |
| Scilex Pharmaceuticals INC. | $19.10 | 2022 | |
| Eisai INC. | $17.02 | 2021 | |
| Abbott Laboratories | $16.20 | 2024 | Proclaim |
| Convatec INC. | $15.38 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.58 | 2025 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Croker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.